Two Sigma Advisers’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-644,726
Closed -$64M 2562
2019
Q3
$64M Sell
644,726
-1,018,400
-61% -$96.8M 0.16% 155
2019
Q2
$154M Sell
1,663,126
-996,701
-37% -$94.6M 0.38% 53
2019
Q1
$251M Sell
2,659,827
-565,300
-18% -$49.4M 0.63% 23
2018
Q4
$207M Buy
3,225,127
+579,600
+22% +$42.8M 0.56% 27
2018
Q3
$237M Sell
2,645,527
-459,700
-15% -$40.6M 0.58% 29
2018
Q2
$247M Buy
3,105,227
+473,900
+18% +$39.3M 0.66% 21
2018
Q1
$235M Sell
2,631,327
-502,800
-16% -$48.3M 0.64% 19
2017
Q4
$327M Buy
3,134,127
+2,454,703
+361% +$277M 0.88% 6
2017
Q3
$99.1M Buy
679,424
+632,537
+1,349% +$86.2M 0.28% 95
2017
Q2
$6.09M Sell
46,887
-317,593
-87% -$38.9M 0.02% 675
2017
Q1
$45.4M Buy
364,480
+144,681
+66% +$17.3M 0.15% 175
2016
Q4
$25.4M Sell
219,799
-1,559,009
-88% -$174M 0.1% 250
2016
Q3
$186M Buy
1,778,808
+1,693,322
+1,981% +$183M 0.79% 16
2016
Q2
$8.43M Buy
85,486
+79,572
+1,345% +$8.23M 0.04% 409
2016
Q1
$592K Sell
5,914
-3,129
-35% -$322K ﹤0.01% 1390
2015
Q4
$1.08M Sell
9,043
-174,793
-95% -$20.2M 0.01% 991
2015
Q3
$19.9M Buy
183,836
+174,296
+1,827% +$21.6M 0.13% 209
2015
Q2
$1.1M Buy
+9,540
New +$1.09M 0.01% 1080
2015
Q1
Sell
-29,644
Closed -$3.32M 2682
2014
Q4
$3.32M Buy
+29,644
New +$3.13M 0.03% 624
2014
Q2
Sell
-10,986
Closed -$835K 2893
2014
Q1
$766K Buy
10,986
+7,800
+245% +$618K 0.01% 1310
2013
Q4
$269K Sell
3,186
-35,200
-92% -$2.79M ﹤0.01% 1965
2013
Q3
$2.95M Sell
38,386
-55,800
-59% -$3.91M 0.04% 472
2013
Q2
$5.51M Buy
+94,186
New +$5.67M 0.08% 228

Other funds holding CELG

Two Sigma Advisers's CELG Position: Q4 2019 in Review

Two Sigma Advisers sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 644,726 shares — an estimated $64M sold.

Two Sigma Advisers first reported a position in CELG in Q2 2013 and held it in 23 quarters. The position peaked at $327M in Q4 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Two Sigma Advisers reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Two Sigma Advisers sold 644,726 Celgene Corp shares in Q4 2019, an estimated $64M.
  • Two Sigma Advisers first reported a position in Celgene Corp in Q2 2013 and held it in 23 quarters.
  • Two Sigma Advisers's Celgene Corp position peaked at $327M in Q4 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Two Sigma Advisers's 13F filing for Q4 2019, filed 14 Feb 2020.